Glen Maberly
Western Sydney Local Health District, NSW, Australia
- This delegate is presenting an abstract at this event.
Professor Glen F Maberly
Senior Staff Specialist Endocrinology
Blacktown and Mt Druitt Hospitals
Director
Western Sydney Diabetes Initiative
Western Sydney Local Health District
Dr Glen Maberly is a Senior Staff Specialist Endocrinologist at Blacktown and Mt Druitt Hospitals, and Director of Western Sydney Diabetes (WSD) at Western Sydney Local Health District. Western Sydney Local Health District (WSLHD), NSW Department of Premier and Cabinet, Western Sydney Primary Health Network (WSPHN), Pricewaterhouse Cooper (PwC), Diabetes NSW and ACT have developed a strategy to ‘take the heat out of the western Sydney diabetes hotspot’. WSD goal is to increase the proportion of healthy population, slow the progression towards being at risk of diabetes, and reduce the size of the risk population.
All his career Glen has focused on fostering public-private-civic partnerships and bring public health evidence based research findings to large scale implementation. Glen Maberly was the founding Director of the Centre for Health Innovation and Partnership (CHIP), March 2009, in the then Sydney West Area Health Service (SWAHS). Previous to that Glen was the founding Executive Director of the Iodine Network, the Flour Fortification Initiative and Rice Fortification Network working with the UN organisations, Global Public Health organisations and agro business to reduce the global burden of vitamin and mineral deficiency in over 120 countries around the world. This is adding billions of IQ points, reducing infant mortality by at least 10 percent in the developing nations and preventing millions of birth defects each year.
Presentations this author is a contributor to:
An evaluation: Educating primary healthcare nurses in general practice to better manage patients with diabetes (#381)
2:00 PM
Sian Bramwell
ADEA Poster Viewing Two
Gaining clinical experience using continuous glucose monitoring system (CGM) in people with type 2 diabetes mellitus (T2DM) (#306)
2:00 PM
Amy N H Nguyen
ADS Clinical Poster Session - Glucose monitoring
Real-world experience with Dapagliflozin in people with type-2 diabetes living in Western Sydney: Beneficial impact on biomarkers and reasons for discontinuation. (#257)
2:00 PM
Tristan Nguyen
ADS Clinical Poster Session - Therapy of type 2 diabetes
Using an app to engage and educate people with diabetes in western sydney (#148)
9:30 AM
Glen Maberly
ADS ADEA Joint Technology Symposium: The future is now – technologies changing diabetes care